1. Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions. (December 2019) Authors: English, Andrew; Irwin, Nigel Journal: Clinical medicine insights Issue: Volume 12(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of 2 Novel PYY(1-36) Analogues, (P3L31P34)PYY(1-36) and PYY(1-36)(Lys12PAL), on Pancreatic Beta-Cell Function, Growth, and Survival. (June 2019) Authors: Lafferty, Ryan A; Gault, Victor A; Flatt, Peter R; Irwin, Nigel Journal: Clinical medicine insights Issue: Volume 12(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A novel neurotensin/xenin fusion peptide enhances β-cell function and exhibits antidiabetic efficacy in high-fat fed mice. Issue 8 (27th August 2021) Authors: Perry, Rachele A.; Craig, Sarah. L.; Gault, Victor A.; Flatt, Peter R.; Irwin, Nigel Journal: Bioscience reports Issue: Volume 41:Issue 8(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Enzymatically stable analogue of the gut‐derived peptide xenin on beta‐cell transdifferentiation in high fat fed and insulin‐deficient Ins1Cre/+;Rosa26‐eYFP mice. Issue 3 (18th August 2020) Authors: Tanday, Neil; Moffett, R. Charlotte; Gault, Victor A.; Flatt, Peter R.; Irwin, Nigel Journal: Diabetes/metabolism research and reviews Issue: Volume 37:Issue 3(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Beneficial actions of a long‐acting apelin analogue in diabetes are related to positive effects on islet cell turnover and transdifferentiation. Issue 12 (21st September 2020) Authors: Tanday, Neil; Irwin, Nigel; Moffett, R. Charlotte; Flatt, Peter R.; O'Harte, Finbarr P. M. Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 12(2020) Page Start: 2468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Amplifying the antidiabetic actions of glucagon‐like peptide‐1: Potential benefits of new adjunct therapies. Issue 12 (7th October 2021) Authors: Tanday, Neil; Flatt, Peter R.; Irwin, Nigel Journal: Diabetic medicine Issue: Volume 38:Issue 12(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Islet distribution of Peptide YY and its regulatory role in primary mouse islets and immortalised rodent and human beta-cell function and survival. (15th November 2016) Authors: Khan, Dawood; Vasu, Srividya; Moffett, R. Charlotte; Irwin, Nigel; Flatt, Peter R. Journal: Molecular and cellular endocrinology Issue: Volume 436(2016) Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Beneficial metabolic effects of recurrent periods of beta‐cell rest and stimulation using stable neuropeptide Y1 and glucagon‐like peptide‐1 receptor agonists. Issue 12 (11th August 2022) Authors: Tanday, Neil; Lafferty, Ryan A.; Flatt, Peter R.; Irwin, Nigel Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 12(2022) Page Start: 2353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Potential Therapeutic Role for Apelin and Related Peptides in Diabetes: An Update. (February 2022) Authors: Palmer, Ethan S; Irwin, Nigel; O'Harte, Finbarr PM Journal: Clinical medicine insights Issue: Volume 15(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Ψ-Xenin-6 enhances sitagliptin effectiveness, but does not improve glucose tolerance. Issue 2 (May 2020) Authors: Craig, Sarah L; Gault, Victor A; Hamscher, Gerd; Irwin, Nigel Journal: Journal of endocrinology Issue: Volume 245:Issue 2(2020) Page Start: 219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗